Tried-and-True Recipes for Success

Interview with IRRAS CEO Will Martin

Will Martin is an accomplished executive with over two decades of medtech experience. In this riveting discussion, we delve into Will’s journey that led him to become the CEO at IRRAS, a medical device company aiming to revolutionize the treatment of patients with intracranial bleeding.

Will embarked on his medical device career somewhat out of necessity. After the internet bubble crash in the early 2000s, he started working in medical sales at Boston Scientific. At the time, he didn’t know this would be a great launching pad for his career. Over time, his extensive expertise in product management, business development, sales, and marketing have further propelled him on his journey across various medtech startups.

In 2007, Will joined startup Access Closure as part of the commercial field sales team. Here, he was exposed to the process of building a new category from the ground up and had the chance to get involved in various aspects of the business beyond customer relationships. As a result of this experience, he later worked for firms like Hotspur Technologies, Athromed, Philips, and, eventually, IRRAS.

At IRRAS, Will is determined to fill the innovation gap in treating patients with intracranial bleeding. The company's flagship technology, IRRAflow, aims to offer a digital and proactive approach to treating intracranial bleeding by combining fluid removal, patient monitoring, automated irrigation, and targeted therapeutic drug delivery. The goal is to help healthcare professionals work smarter, not harder.

Under Will's guidance, IRRAS has made significant strides in commercializing this groundbreaking technology. The company has secured regulatory clearances and approvals not only in the United States but in several international markets, too. 

Moreover, IRRAS recently solidified a commercial partnership with Medtronic in the United States, further bolstering the company's growth prospects.

Key Learnings From Will’s Experience

  • Go the extra mile in meeting users' needs by considering every facet of their experience.

  • Establishing solid, genuine relationships with customers and influential thought leaders is one of the best things you can do for your company. 

  • Keep your eye on the ball when it comes to quality management, which will ensure your company is ready for a successful M&A event

Premium Members Only

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You May Like These Articles

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Medsider Mentors

Medsider Mentors

Medsider Playbooks

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.

Copyright © Medsider 2025 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2025 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2025 • All rights reserved.

Subscribe

Sign In

Suggest a Guest